Deferiprone Tablet, Coated
Product Images NDC 0054-0576

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Deferiprone (NDC 0054-0576). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hikma Pharmaceuticals Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Deferiprone-chem-structure.jpg (Deferiprone Chem Structure)

FDA Label Image

Deferiprone-tabs-bl-100s (Image 01)

Deferiprone-tabs-bl-100s (Image 01)
This is a description of a medication for the treatment of iron overload, Deferiprone, manufactured by Pharmaceuticals USA Inc. and distributed by Hikma. It comes in a film-coated tablet form with each tablet containing 500mg of Deferiprone. A usual dosage recommendation is included in the packaging alongside prescribing information. The medication guide should also be given to each patient, with storage instructions stating it should be kept at 20-25°C (68°F to 77°F) and kept out of reach of children.*
FDA Label Image

Deferiprone-tabs-bl-500mg-300s (Image 02)

Deferiprone-tabs-bl-500mg-300s (Image 02)
This is a medication called Deferiprone which comes in a bottle containing 300 tablets, and each tablet consists of 500mg of Deferiprone. The recommended dosage for this medication can be found in the package leaflet. It is important to keep it away from children and store it at room temperature. Dispensing medication guide to every patient is highly recommended. The product is manufactured by Hikma Pharmaceuticals USA Inc.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.